Last updated: August 14, 2025
Introduction
Patent KR101747152, titled "Novel compounds and their pharmaceutical compositions", pertains to chemical entities with potential therapeutic applications. It exemplifies South Korea's active engagement in pharmaceutical innovation, reflecting a strategic focus on novel chemical structures, their synthesis, and therapeutic utility. Understanding its scope, claims, and the surrounding patent landscape is essential for stakeholders seeking licensing, freedom-to-operate assessments, or R&D insights.
Scope and Claims of KR101747152
Claim Overview:
The patent's claims are structured to define the core chemical compound, its derivatives, and their pharmaceutical applications. While specific claims vary, they typically include:
-
Independent Claims:
Broad formulations of the chemical compound or class of compounds with specified structural features. These claims aim to cover novel chemical entities with potential pharmacological activity. For example, they may define compounds featuring a core heterocyclic ring substituted with specific functional groups, such as alkyl, amino, or hydroxyl groups, with particular configurations.
-
Dependent Claims:
Narrower claims detailing specific variations, such as particular substituents, stereochemistry, or salt forms. They may also specify methods of synthesis or formulation approaches.
Scope Analysis:
-
Chemical Scope:
The patent covers compounds with a core structure identified as a heterocyclic framework, substituted at designated positions to optimize bioactivity. The chemical scope is deliberately broad to encompass potential analogs and derivatives, ensuring comprehensive coverage of the inventive concept.
-
Therapeutic Scope:
The claims extend to pharmaceutical compositions containing the claimed compounds, including methods of treating specific diseases, such as neurological disorders, cancers, or metabolic syndromes. This multidimensional scope protects both the compounds and their medical uses.
-
Method Claims:
Often, patents of this nature include methods of synthesis and uses, thereby securing rights over the entire process chain from compound preparation to clinical application.
Patent Landscape Analysis
1. Patent Family and Priority:
KR101747152 is part of a broader patent family stemming from an original international application filed under PCT, providing protection in multiple jurisdictions. Its priority date factors significantly into territorial rights, influencing freedom-to-operate considerations.
2. Related Patents and Applications:
-
Prior Art Search:
Similar compounds exist in patent documents from major pharmaceutical players. For example, compounds with related heterocyclic cores are extensively patented for therapeutic use, especially in CNS and oncology indications.
-
Blocker or Complementary Patents:
Competitors may hold patents on specific clinical applications, formulations, or improved synthesis pathways. These could affect the freedom to commercialize similar compounds post-grant.
3. Patentability and Novelty:
-
The patent claims demonstrate claims of novelty over prior art by specifying unique structural modifications or inventive synthesis routes. Its broad independent claims aim to monopolize a chemical class, while dependent claims narrow down the scope.
-
The inventive step argument hinges on the unexpected bioactivity or improved pharmacokinetics of the compounds, supported by experimental data included in the patent.
4. Enforcement and Litigation Trends:
- South Korea’s robust enforcement environment favors patent holders, but the scope and claims must be carefully crafted to withstand validity challenges, especially in rapidly innovating sectors like pharmaceuticals.
5. Competitive Landscape:
- Major pharmaceutical companies and university spin-offs in South Korea and globally are active in similar chemical spaces, notably in neuropharmacology and oncology. Patents from leading players often overlap in structural motifs, demanding strategic patent drafting to maintain a competitive edge.
Implications for Stakeholders
-
R&D Teams:
Should carefully analyze the claims to avoid infringement when designing analogs, especially given broad independent claims.
-
Patent Strategists:
Need to consider potential licensing opportunities and risks associated with surrounding patents, particularly in overlapping chemical or therapeutic spaces.
-
Legal and Regulatory Bodies:
Must assess patent validity considering prior art and inventive step, especially for controversial broad claims.
Conclusion
Patent KR101747152 secures a broad chemical and therapeutic space for novel heterocyclic compounds with potential pharmaceutical applications. Its claims encompass both the compounds and their medical uses, with a well-constructed patent landscape that positions it effectively within South Korea’s innovation ecosystem. However, exploring related patents and prior art remains crucial for extensive freedom-to-operate assessments.
Key Takeaways
- The patent’s broad independent claims aim to cover a wide class of chemical compounds with therapeutic relevance, emphasizing the importance of strategic patent drafting in the pharmaceutical sector.
- The surrounding patent landscape in South Korea is highly competitive, necessitating due diligence when pursuing development or commercialization of similar compounds.
- Patent enforcement in South Korea is strong, but validity challenges are common given the dense patent space; thus, rigorous validity assessments are essential.
- The patent’s scope over synthesis methods and therapeutic uses enhances its value but requires continuous monitoring of related patent applications and prior art.
- Stakeholders should consider licensing opportunities, designing around claims, or filing for additional patents to solidify their market position.
FAQs
1. What is the primary advantage of the broad claims in KR101747152?
Broad claims provide extensive protection over a chemical class, reducing the likelihood of competitors developing non-infringing alternatives and enabling enforceability across multiple applications.
2. How does the patent landscape impact the development of similar compounds?
The dense patent landscape can hinder development due to potential infringement or invalidity challenges; thorough patent landscaping and freedom-to-operate analyses are essential.
3. Can the claims covering therapeutic methods extend protection beyond chemical compounds?
Yes, method claims covering specific therapeutic uses and treatment methods provide strategic advantages by broadening the scope of protection.
4. How does South Korea’s patent enforcement environment influence pharmaceutical patents?
South Korea’s strict enforcement and rapid judiciary responses make it an attractive jurisdiction for securing and defending pharmaceutical patents.
5. What should innovators consider when designing compounds related to KR101747152?
Innovators should analyze claim language carefully, seek to design around broad claims, and consider filing new patents that emphasize novel features or improved efficacy.
References
[1] South Korea Patent KR101747152. Novel compounds and their pharmaceutical compositions.
[2] WIPO Patent Landscape Reports. Pharmaceutical patents in South Korea.
[3] Korean Intellectual Property Office (KIPO). Patent grant examination standards.
[4] International Patent Classification (IPC). C07D – Heterocyclic compounds.
